James F. Kronauge serves as Executive at Molecular Insight Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James F. Kronauge has executed 3 insider transactions totaling $15.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 27, 2007 involved purchasing 7 shares valued at $46.
James F. Kronauge currently holds 48,224 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James F. Kronauge has been a net buyer of MIPI stock. They have purchased $15.6K and sold $0 worth of shares.
James F. Kronauge's most recent insider trade was on Nov 27, 2007, when they purchased 7 shares at $6.50 per share.
Get notified when new Form 4 filings are submitted
| $6.50 |
| Discretionary |
| Feb 1, 2007 | MIPI | $43.2M | Conversion | 6,569 | $6569.00 | Discretionary |